The Accelerated Access Review is published today. Readers with long memories will recall that it kicked off in the Spring of 2015 aimed at accelerating the uptake of innovation in to the NHS. It had three technical streams – pharma, medtech & digital health, plus a patient stream. This editor, as Managing Director of DHACA, was the digital health champion.
DHACA members were heavily engaged in the consultation, so it is gratifying to see that all DHACA recommendations were accepted. Most important were recommendations that:
- NICE broaden its reach to include more medtech & digital health recommendations, and consider other means of funding;
- there be closer alignment of regulatory and NICE data requirements and processes (currently, there can be duplication);
- a strategic commercial unit is established in the NHS;
- a small amount of funding is offered to support the commercialisation of disruptive innovative technologies that significantly change care pathways;
- products not referred to NICE should be assessed only once by NHSE;
- the route for digital products should build on the “Paperless 2020” simplified app assessment process;
- the Crown Commercial Service, in partnership with NHS Digital, NHS England, the Department of Health and other system and technology partners, should consider how best to develop an accessible, simple and swift competitive process for procuring digital products from SMEs;
- NHS England, working with NHS Digital, should develop a generic framework for app prescription.
When implemented, these and all the other recommendations in the report will go a long way to (more…)
Most Recent Comments